Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancerGuruFocus · 2 days ago
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trialGuruFocus · 2 days ago
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential SymposiumGuruFocus · 3 days ago
CROSS TIMBERS ROYALTY TRUST DECLARES OCTOBER CASH DISTRIBUTIONPRNewsWire · 6 days ago
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation OncologistsGuruFocus · Oct 6, 2026
Analyzing Cross Timbers Royalty Trust (NYSE:CRT) and Navigator (NYSE:NVGS)Defense World · Oct 4, 2026Cross Timbers Royalty Trust functions as an express trust within the United States, holding substantial stakes in various energy-related assets. The trust maintains a 90% net profits interest across a selection of producing and nonproducing royalty and overriding royalty properties located in Texas, Oklahoma, and New Mexico. Additionally, it secures a 75% net profits working interest in seven specific properties, four of which are situated in Texas and three in Oklahoma.